To summarize, our study is the first to demonstrate that vitexin can effectively inhibit the proliferation of colorectal carcinoma cells by inhibiting HSF-1 activity, and lead to cell death by inducing autophagy mediated by JNK and ApoL1 activation. The gene discussed is APOL1; the disease is colorectal carcinoma.